Could a common drug help when schizophrenia treatments fail?
NCT ID NCT04887792
First seen Apr 14, 2026 · Last updated May 08, 2026 · Updated 3 times
Summary
This study tests whether adding acetazolamide to standard antipsychotic medication can reduce symptoms in people with treatment-resistant schizophrenia. About 60 adults aged 18-55 will receive either acetazolamide or a placebo for a set period, while continuing their usual medication. The main goal is to see if positive symptoms like hallucinations or delusions improve.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St John's Medical College Hospital
RECRUITINGBangalore, India
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.